{
    "Trade/Device Name(s)": [
        "StatStrip Xpress Glucose Hospital Meter System"
    ],
    "Submitter Information": "Nova Biomedical Corporation",
    "510(k) Number": "K150461",
    "Predicate Device Reference 510(k) Number(s)": [
        "K132121"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "PZI"
    ],
    "Summary Letter Date": "March 1, 2019",
    "Summary Letter Received Date": "February 23, 2015",
    "Submission Date": "February 20, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "POCT"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary finger stick whole blood",
        "Venous whole blood",
        "Arterial whole blood",
        "Neonate arterial whole blood",
        "Neonate heel stick whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "StatStrip Xpress Glucose Hospital Meter",
        "StatStrip Glucose Test Strips"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control",
        "Linearity Solution"
    ],
    "Document Summary": "FDA 510(k) summary for the StatStrip Xpress Glucose Hospital Meter System for quantitative glucose determination in various whole blood specimens in hospital and professional healthcare settings",
    "Indications for Use Summary": "Intended for point-of-care, in vitro diagnostic, multiple-patient use for quantitative determination of glucose in capillary finger stick, venous whole blood, arterial whole blood, neonate arterial whole blood and neonate heel stick specimens; not for diagnosis of diabetes mellitus but for determining dysglycemia.",
    "fda_folder": "Clinical Chemistry"
}